Workflow
Cars.com(CARS) - 2025 Q4 - Annual Report
2026-02-26 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37869 Cars.com Inc. (Exact name of Registrant as specified in its Charter) Delaware 81-3693660 (State or other jurisdiction of incorp ...
Rocket Pharmaceuticals(RCKT) - 2025 Q4 - Annual Report
2026-02-26 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36829 Rocket Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3475813 (State or Other Jurisdic ...
Fidus Investment (FDUS) - 2025 Q4 - Annual Results
2026-02-26 21:06
Exhibit 99.1 FIDUS INVESTMENT CORPORATION ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS Board of Directors Declared Total Dividends of $0.52 per Share for First Quarter 2026 Base Dividend of $0.43 and Supplemental Dividend of $0.09 Per Share EVANSTON, Ill., February 26, 2026 – Fidus Investment Corporation (NASDAQ:FDUS) ("Fidus" or the "Company"), a provider of customized debt and equity financing solutions, primarily to lower middle-market companies based in the United States, today announce ...
Expensify(EXFY) - 2025 Q4 - Annual Report
2026-02-26 21:05
FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41043 EXPENSIFY, INC. (Exact name of registrant as specified in its charter) | Delaware | 27-0239450 | | --- | --- | | (State or other jurisdict ...
NetApp(NTAP) - 2026 Q3 - Quarterly Results
2026-02-26 21:05
Exhibit 99.1 NetApp Reports Third Quarter of Fiscal Year 2026 Results Net revenues of $1.71 billion for the third quarter, 4% year-over-year increase; Third quarter GAAP earnings per share of $1.67; record non-GAAP earnings per share of $2.12 News Summary SAN JOSE, Calif.—February 26, 2026—NetApp (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today reported financial results for the third quarter of fiscal year 2026, which ended on January 23, 2026. "We are pleased to announce another strong q ...
PROCEPT BioRobotics (PRCT) - 2025 Q4 - Annual Report
2026-02-26 21:04
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 10-K ___________________________________ (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-04321 ___________________ ...
Syndax(SNDX) - 2025 Q4 - Annual Report
2026-02-26 21:04
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-37708 Syndax Pharmaceuticals, Inc. (Exact name of Registrant as specified in its charter) Delaware 2834 32-0162505 (State or Other J ...
Expensify(EXFY) - 2025 Q4 - Annual Results
2026-02-26 21:04
Exhibit 99.1 EXPENSIFY ANNOUNCES Q4 AND FULL YEAR FISCAL 2025 RESULTS The company generated $20.1 million in operating cash flow and $19.9 million in free cash flow in fiscal year 2025 SAN FRANCISCO, Cal.--(BUSINESS WIRE)--February 26, 2026-- Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today released a letter to shareholders from Founder and CEO David Barrett alongsid ...
Fortrea (FTRE) - 2025 Q4 - Annual Report
2026-02-26 21:04
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K __________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-41704 __________________________________ Fortrea Holdings Inc. (Exac ...
MP Materials(MP) - 2025 Q4 - Annual Results
2026-02-26 21:04
Exhibit 99.1 MP Materials Reports Fourth Quarter and Full Year 2025 Results Produced first NdFeB magnets on commercial equipment at Independence Awarded $200 million incentive package for new 10X magnetics facility to be constructed in Northlake, Texas Produced record 2,599 metric tons of NdPr oxide in 2025, a 101% increase year-over-year Sold record 1,994 metric tons of NdPr oxide in 2025, a 75% increase year-over-year 1 Produced record 50,692 metric tons of REO in concentrate in 2025, a 12% increase year- ...